BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37534654)

  • 1. [Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma].
    Xie S; Cai ZG; Shan XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):697-701. PubMed ID: 37534654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
    Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
    Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
    Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
    Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation detection in saliva from oral cancer patients.
    Ahmed AA; Sborchia M; Bye H; Roman-Escorza M; Amar A; Henley-Smith R; Odell E; McGurk M; Simpson M; Ng T; Sawyer EJ; Mathew CG
    Oral Oncol; 2024 Apr; 151():106717. PubMed ID: 38412584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
    Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
    Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
    Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
    Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
    Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
    Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
    Eder T; Hess AK; Konschak R; Stromberger C; Jöhrens K; Fleischer V; Hummel M; Balermpas P; von der Grün J; Linge A; Lohaus F; Krause M; Baumann M; Stuschke M; Zips D; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Budach V; Tinhofer I;
    Eur J Cancer; 2019 Jul; 116():67-76. PubMed ID: 31173964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
    Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
    Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden.
    Wu F; Du Y; Hou X; Cheng W
    BMC Oral Health; 2022 Apr; 22(1):152. PubMed ID: 35488327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma.
    Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK
    Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance.
    Batta N; Pandey M
    World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Invasive Saliva-based Detection of Gene Mutations in Oral Cancer Patients by Oral Rub and Rinse Technique.
    D'Cruz A; Dechamma PN; Saldanha M; Maben S; Shetty P; Chakraborty A
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3287-3291. PubMed ID: 34711005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational genomics and recent advances in oral squamous cell carcinoma.
    Chai AWY; Lim KP; Cheong SC
    Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of programmed death-ligand 1 protein expression between primary tumors and lymph node metastatic lesions in oral squamous cell carcinoma].
    Xia RH; Hu YH; Zhang CY; Xu SM; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Nov; 57(11):1113-1118. PubMed ID: 36379889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.